Human interferon alfa-2b (Sinovac Biotech)

人干扰素α2b（科兴生物）

Report date: 2022/10/28 15:48:54

Base Information

Drug NameHuman interferon alfa-2b (Sinovac Biotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVaginitisUterine CervicitisHerpes Labialis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShandong Kexing Bio-Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Kexing Bio-Products Co LtdShenzhen Kexing Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsVaginitisUterine CervicitisHerpes Labialis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A